Decisive point for gensight in the short termSolid'action which is about to exceed probably € 10 in the short term if we go above € 9.35 at 11:45 am.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.3535EUR
−26.22 MEUR
1.27 MEUR
82.58 M
About GENSIGHT BIOLOGICS
Sector
CEO
Laurence Rodriguez
Headquarters
Paris
Website
Founded
2012
ISIN
FR0013183985
FIGI
BBG00JHW7HX8
GenSight Biologics SA is a clinical-stage gene therapy company, which engages in research and development of novel therapies for mitochondrial and neurodegenerative diseases of the eye. It also focuses on central nervous system diseases. The company was founded by Bernard Jacques Alex Gilly, Botond Roska, Jean Bennett, Connie Cepko, Luk H. Vandenberghe, Serge Picaud and Jose-Alain Sahel in 2012 and is headquartered in Paris, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0RIM is 0.3300 EUR — it has decreased by −12.63% in the past 24 hours. Watch GENSIGHT BIOLOGICS SA EUR0.025 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange GENSIGHT BIOLOGICS SA EUR0.025 stocks are traded under the ticker 0RIM.
0RIM stock has risen by 1.15% compared to the previous week, the month change is a −16.73% fall, over the last year GENSIGHT BIOLOGICS SA EUR0.025 has showed a −23.62% decrease.
We've gathered analysts' opinions on GENSIGHT BIOLOGICS SA EUR0.025 future price: according to them, 0RIM price has a max estimate of 0.36 EUR and a min estimate of 0.36 EUR. Watch 0RIM chart and read a more detailed GENSIGHT BIOLOGICS SA EUR0.025 stock forecast: see what analysts think of GENSIGHT BIOLOGICS SA EUR0.025 and suggest that you do with its stocks.
0RIM reached its all-time high on May 25, 2021 with the price of 9.9900 EUR, and its all-time low was 0.2800 EUR and was reached on Oct 23, 2024. View more price dynamics on 0RIM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0RIM stock is 6.71% volatile and has beta coefficient of 0.96. Track GENSIGHT BIOLOGICS SA EUR0.025 stock price on the chart and check out the list of the most volatile stocks — is GENSIGHT BIOLOGICS SA EUR0.025 there?
Today GENSIGHT BIOLOGICS SA EUR0.025 has the market capitalization of 32.93 M, it has increased by 13.14% over the last week.
Yes, you can track GENSIGHT BIOLOGICS SA EUR0.025 financials in yearly and quarterly reports right on TradingView.
GENSIGHT BIOLOGICS SA EUR0.025 is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
0RIM net income for the last half-year is −5.85 M EUR, while the previous report showed −14.24 M EUR of net income which accounts for 58.93% change. Track more GENSIGHT BIOLOGICS SA EUR0.025 financial stats to get the full picture.
No, 0RIM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 16.00 employees. See our rating of the largest employees — is GENSIGHT BIOLOGICS SA EUR0.025 on this list?
Like other stocks, 0RIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENSIGHT BIOLOGICS SA EUR0.025 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENSIGHT BIOLOGICS SA EUR0.025 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENSIGHT BIOLOGICS SA EUR0.025 stock shows the sell signal. See more of GENSIGHT BIOLOGICS SA EUR0.025 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.